StockData
Merck & Co., Inc. logo

Merck & Co., Inc. (MRK) operating KPIs

MRKNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026Score 9/30242% above fair value
$146.33+5.40 (+3.83%)

Close on Oct 29, 2026Market cap $361.02BP/E 117.1Yield 2.24%

Merck gain (Loss) on Equity Investments ($M) ($M)

Postgres DB financial_values

QuarterlyAnnual
Latest, Q2 2026
242
Period ended Jun 30, 2026
Change on a year earlier
+142.0%
100 in Q2 2025
History
34 quarters
Since Q1 2018
Sources
30
Documents cited below

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedGain (Loss) on Equity Investments ($M) ($M)Year on yearSource
Q2 2026Jun 30, 2026242+142.0%Form 10-Q (filed 2026-08-07) ↗
Q1 2026Mar 31, 2026168+86.7%Form 10-Q (filed 2026-05-04) ↗
Q4 2025Dec 31, 2025-195+25.8%Form 10-K (filed 2026-02-24) ↗
Q3 2025Sep 30, 2025373-1,303.2%Form 10-Q (filed 2025-11-05) ↗
Q2 2025Jun 30, 2025100+78.6%Form 10-Q (filed 2025-08-05) ↗
Q1 2025Mar 31, 202590-37.1%Form 10-Q (filed 2025-05-02) ↗
Q4 2024Dec 31, 2024-155-255.0%Form 10-K (filed 2025-02-25) ↗
Q3 2024Sep 30, 2024-31-6.1%Form 10-Q (filed 2024-11-06) ↗
Q2 2024Jun 30, 202456-132.0%Form 10-Q (filed 2024-08-05) ↗
Q1 2024Mar 31, 2024143-68.2%Form 10-Q (filed 2024-05-03) ↗
Q4 2023Dec 31, 2023100-272.4%Form 10-K (filed 2024-02-26) ↗
Q3 2023Sep 30, 2023-33-91.1%Form 10-Q (filed 2023-11-03) ↗
Q2 2023Jun 30, 2023-175-38.4%Form 10-Q (filed 2023-08-07) ↗
Q1 2023Mar 31, 2023450-163.6%Form 10-Q (filed 2023-05-05) ↗
Q4 2022Dec 31, 2022-58-114.3%Form 10-K (filed 2023-02-24) ↗
Q3 2022Sep 30, 2022-371-154.3%Form 10-Q (filed 2022-11-03) ↗

Cite this data

StockData. (2026). Merck Gain (Loss) on Equity Investments ($M) ($M), quarterly Q1 2018–Q2 2026 [Data set]. Compiled from Merck SEC filings and investor materials. https://stockdatahq.com/stocks/mrk/kpis/db_inc_inv_gain

See every metric in the Merck KPI table. Data updated Oct 26, 2026.